Affiliation:
1. Faculty of Medicine, University of Queensland , Brisbane , Australia
2. Department of Respiratory & Sleep Medicine, Princess Alexandra Hospital , Brisbane , Australia
3. Institute of Health and Biomedical Innovation, Queensland University of Technology , Brisbane , Australia
Abstract
Abstract
Study Objectives
The objective of this study was to investigate the association between demographic, clinical, and interface factors and noninvasive ventilation (NIV) usage.
Methods
A retrospective cohort analysis of 478 patients prescribed NIV from 2013 to 2021 was performed. Demographic factors, clinical indications for NIV, and interface factors were collected, and linear regression was conducted to evaluate the association between these variables and NIV usage (hour/night).
Results
The average usage of the cohort was 6.5 hour/night ± 4.6, with an average age of 57 years ± 16 and body mass index (BMI) of 40.5kg/m2 ± 14.7. The cohort was mostly male (n = 290, 60.6%). The most common indications for NIV prescription were high-pressure requirement for obstructive sleep apnea (HPR, n = 190, 39.7%), neuromuscular disease (NMD, n = 140, 29.3%), and obesity hypoventilation syndrome (OHS, n = 111, 23.2%). A diagnosis of NMD was a significant predictor of higher NIV usage (8.0 ± 6.1 hour/night) in multivariate analysis (p = .036). The HPR subcohort had the lowest usage of all indications. Age and BMI did not predict usage. A nasal interface (p < .01) and lower expiratory positive airway pressure (EPAP) setting (p < .001) were associated with increased NIV usage.
Conclusions
This study highlights the multifaceted nature of NIV usage. Where demographic factors were not consistent predictors of usage, interface, and clinical indication were associated with usage. These findings highlight that the HPR users are a group at risk of low usage.
Publisher
Oxford University Press (OUP)
Reference25 articles.
1. Home mechanical ventilation in Australia and New Zealand;Garner;Eu Clin Respir J.,2012
2. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD;Ergan;Eur Respir J.,2019
3. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders;Annane;Cochrane Database Syst Rev.,2014
4. Domiciliary noninvasive ventilation in adult patients: a consensus statement;Piper;NSW: Agency Clin Innovation,2012
5. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial;Murphy;JAMA.,2017